/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

W

Wolfgang Mueck

Bayer (Germany)(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

75

Papers

6.3K

Citations

35

h-index

46

i10-index

Wolfgang Mueck is an academic researcher from Bayer (Germany). The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Venous Thromboembolism Diagnosis and Management & Cardiac electrophysiology and arrhythmias. The author has an h-index of 35, co-authored 64 publications.

Research Topics

Atrial Fibrillation Management and Outcomes Venous Thromboembolism Diagnosis and Management Cardiac electrophysiology and arrhythmias Cardiac Arrhythmias and Treatments Blood Coagulation and Thrombosis Mechanisms

Papers by this author

works

Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies

2020 · Clinical Pharmacokinetics · 55 citations

https://doi.org/10.1007/s40262-020-00895-x

Michael Böettcher Michael Gerisch Maximilian T. Lobmeyer Nina Besche

Pharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat

2013 · BMC Pharmacology and Toxicology · 9 citations

https://doi.org/10.1186/2050-6511-14-s1-p5

Corina Becker Reiner Frey Sigrun Unger Dirk Thomas

Results from in vitro and in vivo studies evaluating the bioavailability, effects of food, and administration as crushed tablet suspension on vericiguat pharmacokinetics

2022 · AAPS Open · 5 citations

https://doi.org/10.1186/s41120-022-00063-4

Corina Becker Michael Böettcher Uwe Muenster Stephanie Loewen

Effects of omeprazole and AlOH/MgOH on riociguat absorption

2013 · BMC Pharmacology and Toxicology · 3 citations

https://doi.org/10.1186/2050-6511-14-s1-p6

Corina Becker Reiner Frey Sigrun Unger U. Artmeier-Brandt

Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls

2011 · BMC Pharmacology · 0 citations

https://doi.org/10.1186/1471-2210-11-s1-p61

Christian Scheerans Martin Blunck Wolfgang Mueck Reiner Frey

Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)

2011 · BMC Pharmacology · 0 citations

https://doi.org/10.1186/1471-2210-11-s1-p26

Reiner Frey Wolfgang Mueck Michael Becka Joern Kraetzschmar

Research topics

topics

Atrial Fibrillation Management and Outcomes

Venous Thromboembolism Diagnosis and Management

Cardiac electrophysiology and arrhythmias

Cardiac Arrhythmias and Treatments

Blood Coagulation and Thrombosis Mechanisms

Chat about Author

Papers

Chat

Click to start Chat